Cancer surgery is irreversible. Once tissue is removed, anatomy changes permanently, and the patient pays a physiological price even when recovery goes well. That is why the most important part of surgical oncology is not the incision -- it is the decision that precedes it.
In real practice, two experienced teams can look at the same patient and recommend different sequences (surgery first vs systemic therapy first, or local therapy vs non-operative management). This does not always mean one is "wrong." It often means the decision is being driven by different assumptions about staging accuracy, tumor biology, risk tolerance, and the true goal of care.
Over years of surgical oncology work, I have found that most decision disagreements can be clarified by focusing on ten data points. These are not "interesting details." These are the points that routinely change the plan.
1. Diagnostic certainty
Before any discussion of surgery, ask: is the diagnosis truly established and representative? Errors here can cascade. The most common pitfalls are limited biopsies, sampling error, and pathology that should be reviewed in a higher-volume setting when the clinical picture does not fit.
2. Stage accuracy (and the completeness of staging)
A treatment plan built on incomplete staging is structurally weak. Staging is not only "where the tumor is," but whether there is evidence of regional nodal involvement, distant disease, or high-risk patterns that change the value of local surgery.
3. Resectability
Can the tumor be removed with an oncologically acceptable margin? Resectability is anatomy plus technique. It includes proximity to critical structures, likelihood of margin negativity, and whether the surgery required to achieve margins would cause unacceptable functional loss.
4. Operability
Can the patient safely tolerate the procedure and recover? A technically "resectable" tumor in a physiologically depleted patient can turn into harm. Operability includes performance status, cardiopulmonary reserve, frailty markers, nutritional status, and the patient's recovery capacity.
5. Tumor biology and aggressiveness
Biology often determines whether surgery is the decisive move or just a temporary local event. Histologic grade, biomarker profile, and biological behavior (especially rapid progression) can matter as much as the scan.
6. Disease tempo (the time dimension)
The same imaging pattern can mean different things depending on pace. A stable lesion over months suggests a different strategy than a lesion doubling rapidly. Serial imaging and clinical course are often more informative than a single snapshot.
7. Response to systemic therapy
Response is not just "good news." It is a biology test. A tumor that responds suggests a biology that may reward aggressive local therapy. A tumor that progresses rapidly on first-line therapy often signals that major surgery is unlikely to change the curve.
8. Intent of surgery: cure, durable control, or symptom relief
In surgical oncology, intent is not semantics; it is ethics. Surgery should start only when the primary intent can be written in one sentence and defended. Curative intent has different thresholds than palliation. Palliative surgery can be valuable -- but only with explicit goals.
9. Alternatives that deliver similar benefit with lower burden
Not every "surgical" problem is best solved surgically. Radiotherapy, systemic therapy, endoscopic management, or local ablative approaches may offer similar benefit with lower morbidity in selected contexts.
10. Patient priorities, values, and risk tolerance
Two plans may be medically reasonable but not equally aligned with what the patient values: longevity at any cost vs function, independence, cognitive clarity, or minimizing hospitalization. Shared decision-making is part of evidence-based care.
Common failure modes that make surgery harmful
- Surgery done before diagnostic certainty is established
- Surgery performed with incomplete staging
- Surgery pursued when intent is vague ("maybe it helps")
- Surgery chosen without acknowledging biology and tempo
- Surgery offered without a clear recovery plan and measurable endpoints
A simple way to use this framework
Bring the ten points to your consultation and ask: which of these are confirmed, which are assumptions, and which could change the plan? A strong team can answer that calmly and clearly.
Surgical oncology is at its best when decisions are defendable: grounded in staging, biology, patient reserve, and intent. The goal is not "more intervention." The goal is the right intervention, at the right time, for the right reason.